Who we are
   
News
 
   
 

What's the latest happening at our end?

December 01, 2006 Marketing Authorisation for our product FLUCANZOLE in UK
November 14, 2006 FORBES rates FDC as "BEST UNDER A BILLION COMPANIES
November 14, 2006 FDC ENTERS INTO AN LICENSING AGREEMENT WITH GILEAD SCIENCES INC, FOR MANUFACTURING AND DISTRIBUTION OF GENERIC VERSIONS OF VIREAD IN THE DEVELOPING WORLD
November 14, 2006 FDC LIMITED and AKORN INC, USA, sign exclusive development and Supply Agreement for Two Ophthalmic Suspensions drug Products .
May 12, 2005 Major Achievements in 2004 - 05
March 17, 2005 Interim Dividend
September 11, 2004 Outcome of AGM
August 09, 2004 AGM
June 29, 2004 Audited Results (2003-04)
April 10, 2004 FDC's Ranking
April 02, 2004 Outcome of EGM
February 24, 2004 Bonus
December 30, 2003 New lauches in the Cardiac Segment
December 19, 2003 Setting up of Manufacturing Unit
December 19, 2003 Declaration of Interim Dividend @ 125%
September 08, 2003 South African MCC Approval
September 05, 2003 COS from EDQM for Miconazole Nitrate
September 04, 2003 US - DMF's assigned for Metaxalone & Fluconazole
August 26, 2003 FDC's Grand Venture into the Pain Segment
August 25, 2003 Zodlin & 1-Al
August 24, 2003 Final Dividend for the Year 2002-03
August 11, 2003 FDC Obtains injunction order restraining workmen of Roha Plant from strike
January 15, 2003 Nizi & Osteoshield